CBX733388 1..8 Review The effects of aerobic and anaerobic exercises on circulating soluble-Klotho and IGF-I in young and elderly adults and in CAD patients Moran S Saghiv1, D Ben Sira2, E Goldhammer3, and M Sagiv2 Abstract Different studies support the notion that chronic aerobic exercises training can influence the circulating levels of soluble- Klotho (s-Klotho) and insulin-like growth factor 1 (IGF-I). The effects of s-Klotho include improving the quality of life, alleviating the negative impact of age on the body’s work capacity, and possibly increasing longevity. This review provides an overview of the latest findings in this field of research in humans. The different modes of dynamic exercise and their impact on circulating levels of s-Klotho and IGF-I in young adult athletes, untrained young adults, trained healthy older adults, untrained healthy older adults, and coronary artery disease (CAD) patients are reviewed and discussed. Together these findings suggest that long-lasting (chronic) aerobic exercise training is probably one of the antiaging factors that counteract the aging and CAD process by increasing the circulating s-Klotho and lowering the IGF-I levels. However, following anaerobic exercise training the opposite occurs. The exact metabolic and physiological pathways involved in the activity of these well-trained young and master sportsmen should be further studied and elucidated. The purpose of this review was to provide a clarification regarding the roles of s-Klotho and intensities and durations of different exercise on human health. Keywords Aerobic exercise, epigenetic, aging, anaerobic exercise, coronary artery disease, master athletes, elite athletes Date received: 16 February 2017; accepted: 9 August 2017 Introduction Exercise training can alter gene expression patterns (epige- netic) and the physiological responses at rest and during exercise. 1 Recent studies show that even brief exercise alters gene expression, and the pattern of change involves diverse genetic pathways, consistent with a global danger- type response, for a range of physiological functions from inflammation to tissue repair that would be useful follow- ing a bout of physical activity. 2 Physical exercise offers an epigenetic tendency with benefits in several health domains. Yet, it is only recently that regular exercise has begun to be interpreted as a positive epigenetic mechanism to modify the genome-wide DNA methylation patterns in humans. 1 This is achieved by helping to improve the work capacity and physical performance of humans in health and disease. 3 Since aerobic exercise increases the circulating levels of soluble-Klotho (s-Klotho), the Wnt-signaling transduction gets suppressed, and thus inhibiting cell senes- cence and preserving stem cells. 4 However, the precise mechanism underlying the aerobic exercise–induced 1 Exercise Physiology Department, University of Mary, Bismarck, ND, USA 2 Life Sciences Department, Wingate College, Wingate, Israel 3 Heart Institute Bnai-Zion Haifa Medical Center, Technion Institute, Haifa, Israel Corresponding Author: Moran S. Saghiv, Exercise Physiology Department, Casey Center, Room 141B, University of Mary,7500 University Drive, Bismarck, ND 58504, USA. Email: mssaghiv@umary.edu Journal of Circulating Biomarkers Volume 6: 1–8 ª The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1849454417733388 journals.sagepub.com/home/cbx Creative Commons CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). mailto:mssaghiv@umary.edu https://uk.sagepub.com/en-gb/journals-permissions https://doi.org/10.1177/1849454417733388 http://journals.sagepub.com/home/cbx https://us.sagepub.com/en-us/nam/open-access-at-sage increase in s-Klotho secretion following 12 weeks of moder- ate aerobic exercise training or the elevation in insulin-like growth factor 1 (IGF-I) following anaerobic training remains unclear. 5 The benefits of exercise intensity are positive epi- genetic changes in terms of mitochondrial biogenesis. 6 In addition, exercise training is widely appreciated for its effects on the cardiovascular and musculoskeletal, endocrine, and immune systems. Many of the benefits of exercise training, such as volume overload (such as aerobic exercise) and load overload (such as anaerobic activities), diminish within 2 weeks if physical activity is substantially reduced and dis- appear within 2–8 months if exercise training is not resumed. s-Klotho Klotho is a transmembrane protein that, in addition to other effects, provides some control over the sensitivity of the organism to insulin and appears to be involved in aging. 7 Klotho is highly expressed in the brain, kidney, parathyr- oid, and pituitary glands but also serves as a circulating hormone by which shedding forms s-Klotho which in turn can be detected in blood, cerebrospinal fluid, and urine. 8 The a-Klotho gene is highly conserved forming s-Klotho, a blood circulating protein to be highly conserved across species. In humans, the serum levels of s-Klotho decrease after 40 years of age. Age-related declines are manifested by a decreased ability for aged skeletal muscle to respond to physiological stimuli such as muscle loading or acute injury. Indeed, older adults often exhibit an age-related reduction in the number and size of muscle fibers known as sarcopenia. 9 This decrease in blood s-Klotho levels may be observed in patients with several aging-related diseases such as coronary artery disease (CAD), cancer, hyperten- sion, and kidney disease. 10,11 The Klotho gene encodes a single-pass transmembrane protein that binds to multiple fibroblast growth factor (FGF) receptors and functions as a co-receptor for FGF23, a bone-derived hormone that suppresses phosphate reab- sorption and vitamin D biosynthesis in the kidney. 12 In addition, the extracellular domain of s-Klotho protein is shed, potentially functioning as a humoral factor of Klotho protein. 13 The action mechanism of Klotho is not fully understood, but it changes cellular calcium (Ca) homeos- tasis, by increasing the expression and activity of transient receptor potential cation channels, vanilloid subfamily, member 5 (TRPV5) which plays a key role in active Ca þþ reabsorption in the kidney, and by decreasing the expres- sion and activity of transient receptor potential canonical 6 (TRPC6), a subtype of calcium-permeable channel. 14 Additionally, Klotho increases membrane expression of the inward rectifier Renal Outer Medullary (Potassium Chan- nel) Kinase 1 (ROMK1) channels, that is, renal outer medullary K þ . 14,15 Klotho-deficient mice show increased vitamin D pro- duction, and altered mineral–ion homeostasis is suggested to be a cause of premature aging-like phenotypes because the lowering of vitamin D activity by dietary restriction reverses the premature aging-like phenotypes and prolongs survival in these mutants. These results suggest that aging- like phenotypes were due to Klotho-associated vitamin D metabolic abnormalities. 16,17 The Klotho protein deficiency is known to cause pre- mature aging. Klotho is an important molecule in aging processes and its overexpression results in longevity. 18 The Klotho gene encodes a transmembrane protein that after cleavage is also found as a secreted protein. Importantly, its overexpression suppresses insulin/IGF-I signaling and thus extends life span. In addition, Klotho participates in the regulation of several other intracellular signaling path- ways, including regulation of FGF23 signaling, Cyclic Adenosine Monophosphate (cAMP), Protein Kinase C (PKC), transforming growth factor-b (TGF-b), p53/p21, and Wnt signaling. 12,18 Crasto et al. 19 in a population-based longitudinal study revealed that low plasma levels of Klotho are associated with decreased activities of daily living in older individu- als. In older community-dwelling adults, plasma Klotho is an independent predictor of all-cause mortality. 20 In older, community-dwelling adults, low Klotho levels in plasma have also been associated with a poor muscle strength. 21 IGF-I IGF-I, also called somatomedin C, is a cellular and secreted growth factor critical for normal body growth, development, and maintenance, and plays important roles in multiple bio- logical systems. 22,23 IGF-I is an endocrine and autocrine/ paracrine growth factor with major effects on development, cell growth and differentiation, and tissue repair, and it cir- culates at high levels in the plasma and is expressed in most cell types. 24 A variety of cellular responses are induced by IGF-I, including cell proliferation, differentiation, migration, and survival. 25,26 These cellular responses have implicated IGF-I in several conditions such as the pathophysiology of several cancers, 27 the mitogenic and myogenic processes during muscle development, regeneration, or hypertrophy, since, unlike other growth factors, IGF-I acts as both a mito- gen and a differentiation factor. 28 IGF-I is an important factor that regulates a variety of cellular responses in multiple biological systems. The IGF- I gene comprises a highly conserved sequence and contains six exons, which give rise to heterogeneous mRNA tran- scripts by a combination of multiple transcription initiation sites and alternative splicing. Several protein synthesis and degradation pathways are mediated by IGF-I, which act on the cellular and molecular levels to increase or reestablish the strength, and function of muscle fibers. 29 Deficiency of IGF-I in skeletal muscle may contribute to sarcopenia by severely influencing protein synthesis. IGF-I has anabolic effects on muscle protein content by inhibiting protein degradation and promoting myogenesis. Thus, IGF- I attrition in skeletal muscles is associated with less protein 2 Journal of Circulating Biomarkers synthesis and muscle sarcopenia, 30 stress, and inflamma- tion. 31,32 IGF-I is generally thought to be associated with positive attributes such as growth, health, young look, and well-being, yet the bulk of the scientific evidence suggests that signaling through IGF-I and insulin receptors is related to a shortened life span in adults. 33 Indirect data have sup- ported the concept that IGF-I may be atherogenetic because it can induce vascular smooth muscle cell proliferation in vitro. 34 Thus, IGF-I has been considered a promoter of arterial obstructive lesions. 35 Exercise training, s-Klotho, and IGF-I in healthy subjects Regular participation in physical activity and/or exercise training programs can minimize the physiological altera- tions that occur during aging and may contribute to improvements in health and well-being. 36 When elite ath- letes engaging in various sports are analyzed, their mortal- ity is lower than that of the general population. 37 Thus, long- term moderately vigorous and vigorous exercise training are associated with increased survival rates in specific groups of athletes and CAD patients. 38 There are several studies proving the definitive role of lifelong physical activity, which can be engaged in at any age, 39 even by those in their 80s or 90s. 40,41 . Accordingly, regular aerobic exercise pro- motes older adult health and disease prevention. 36 Endurance exercise like biking, walking, swimming, and running results in longer life expectancy compared to anaerobic exercise like power lifting. 42 The limited data on humans to explore the association between exercise and s- Klotho drove others to explore the relationship between exercise training and plasma s-Klotho levels in mice. 43,44 As a first step to probe the connection between physical activity, age, and Klotho expression, Schefer et al. 43 quan- tified the effect of an acute exercise bout on circulating Klotho levels in mice. It revealed that acute aerobic exer- cise significantly increased the circulating Klotho levels. Avin et al. 9 evaluated in young and older sedentary women the change in circulating Klotho levels before and after completion of an acute aerobic exercise bout. It suggested that circulating Klotho levels are upregulated in response to an acute exercise bout but the response may be dependent on fitness level. Saghiv et al. 45 tested the hypothesis that long-lasting aerobic exercise training could prevent the age-associated reduction in s-Klotho serum levels and increases IGF-I levels, in 30 healthy sportsmen: 15 young aerobically well-trained elite athletes and 15 aerobically well-trained master athletes. This study demonstrated that circulating s- Klotho levels are similar for young healthy well-trained elite runners and elite master athletes. This suggests that the response of s-Klotho depends on the aerobic fitness level. 9,42 In addition, levels of s-Klotho were significantly higher in both groups, when compared with age-matched untrained subjects as reported earlier by Lee et al., 46 suggesting that long-lasting aerobic training may be appro- priate for mechanistically probing the role of physical activity on s-Klotho expression. The human population from birth to 91 years screened previously by enzyme-linked immunosorbent assay (ELISA) revealed that the level of s-Klotho declines was with human physiological aging. 19 On the other hand, elderly with greater aerobic capacity have longer life expectancies compared to inactive people. 47 There are sev- eral studies proving the definitive role of lifelong physical activity, which can be initiated at any age. 39 Compared to sedentary young and old subjects, in the elite aerobic- trained young runners and master athletes, s-Klotho levels are markedly elevated, while IGF-I levels decreased. 48 IGF-I is generally thought to be associated with anabolism and well-being, 49 yet, signaling through IGF-I and insulin receptors is negatively related to adults. 50 A meta-analysis study indicated that increased circulating concentrations of IGF-I are associated with increased risks of colorectal, prostate, and premenopausal breast cancers. 51 Another study on the association between s-Klotho serum levels and IGF-I levels in regular young adults and elderly subjects trained aerobically for their health and well-being 45 demonstrated that following aerobic training in young and elderly subjects circulating s-Klotho levels were found to be significantly higher compared to their untrained counterpartners. The cross-sectional study find- ings in young and aged individuals suggest that circulating s-Klotho levels increase in response to long-lasting aerobic exercise training and that the response depends on fitness level. A similar increase in circulating s-Klotho is also observed in response to an acute exercise in young and old mice, suggesting that this may be a good model for mechanistically probing the role of physical activity on Klotho expression in mammals. 9 While in the aerobic-trained young runners and master athletes, s-Klotho levels were markedly elevated, IGF-I levels were decreased compared with sedentary young and old subjects. 48 The comparative analysis of biochemical indices mea- sured showed that the long-lasting aerobic exercise training causes the significant decrease in IGF-I concentrations, while no differences were noted in untrained subjects. This finding on the reduced IGF-I clarifies the results of a pre- viously reported study 50 that it was impossible to determine whether exercise affects IGF levels. It seems that important methodological differences among studies, as well as con- cerns about study quality, limit the ability to draw firm conclusions in that abovementioned study. A meta- analysis indicated that increased circulating concentrations of IGF-I binding protein 3 (IGFBP-3) are associated with increased risks of colorectal, prostate, and premenopausal breast cancers. 51 Thus, it appears that s-Klotho is a protein that inhibits IGF-I and insulin receptor and IGF-IR signal- ing by inhibiting tyrosine phosphorylation of both receptors and their downstream signaling proteins. 52 Saghiv et al. 3 Anaerobic bouts can be limited by lactic acid levels in the blood and active muscles. It is characterized by expos- ing the subjects to a very high degree of sudden strenuous all-out exercise. Thus, the increase of IGF-I levels in the blood 53 was primarily due to a substantial major increase in plasma catecholamine concentrations. 54 In mice, anaerobic exercise bouts increase inhibition of weight gain and growth rate, which may result from exercise intensity and duration or frequency. 55 While an association between aerobic exercise and s-Klotho expression has been previously suggested from longitudinal cohort studies, 19 a direct relationship between circulating s-Klotho and anaerobic exercise training has been recently investigated. 45 It revealed that levels of s-Klotho in aerobic-trained sportsmen were markedly higher compared to those measured in the anaerobic sprin- ters. These findings on long-lasting anaerobic exercise training suggest that circulating s-Klotho levels in sprinters are similar to those of sedentary young adult males 56 and that the response depends on aerobic fitness level. 42 Following long-lasting aerobic exercise training, s-Klotho levels were markedly elevated and IGF-I levels reduced in the aerobic-trained sportsmen, while in the anaerobically trained sprinters, s-Klotho levels were signif- icantly lower and had higher IGF-I. In the anaerobically trained athletes, the levels of s-Klotho and IGF-I were sim- ilar to those reported previously for sedentary young adults. 57 The reduced s-Klotho levels in the anaerobic sprinters may be associated in later life with increased mortality, increased rate of cardiovascular disease, and dis- ability in daily living activities. 58,59 A recent study on well-trained elite anaerobic sprinters tested on an aerobic bout 60 revealed a positive relationship between circulating plasma s-Klotho concentration and acute aerobic bout lasting 60 min, while the IGF-I levels reduced. However, in long-lasting well-trained elite aero- bic athletes with high levels of circulating s-Klotho to begin with, an acute aerobic bout induced a slight increase in plasma s-Klotho concentration and a significant decrease in IGF-I levels. It seems that the increase in the plasmas s-Klotho con- centration, after 60 min of an aerobic bout in the anaerobic- trained athletes, might be responsible for the decreased IGF-I. Exercise, s-Klotho, and IGF-I in aging The primary aging process occurs both independent of life style and in the absence or presence of disease. 51,61 Aging is a complex multifactorial process that not only involves the natural processes of aging but also the increased risk of different diseases—coronary heart disease, diabetes, and cancer. 62 Studies have demonstrated that when researchers adjust the genes in certain mice, yeast cells, and other organ- isms, they can almost double the life span of these mice. Therefore, successful aging is a function of both genetic and environmental factors. 63,64 Multiple age-related structural and functional changes are involved in skeletal, cardiac, and oxygen delivery-extraction ability during the human senes- cence, resulting in a significant decline in aerobic capacity and in the expression of a gene located on chromosome 13, Klotho gene a suppressor of the aging phenomena as well as the circulation of s-Klotho proteins. 65,66 The Klotho protein deficiency causes premature aging. As an aging suppressor, Klotho is an important molecule in aging processes and its overexpression results in longevity. Due to many reasons, the insulin/IGF-I has been considered as a key pathway in aging research. Because Klotho induces IGF-I and insulin resistance, these findings appear to contradict the previous evidence of increased life span of dwarf mice with reduced IGF-I and insulin levels and enhanced insulin sensitivity. However, activation of signal- ing molecules downstream from IGF-I and insulin recep- tors is reduced in both Klotho and dwarf mice, suggesting common mechanisms of delayed aging. 67 s-Klotho inhibits IGF-I and insulin receptor, IGF-IR signaling, by inhibiting tyrosine phosphorylation of both receptors and their downstream signaling proteins, 68 thus, increasing longevity in mice. 69 Moreover, it has been shown that the blockade of IGF-I signaling induced by s-Klotho increased resistance to oxidative stress, thereby improving survival. 70 Because of genetic factors, work capacity decreases with aging regardless of the lifestyle. Consequently, the maximal oxygen uptake decreases. Such consequences contribute to the geriatric syndrome of frailty, thereby severely limiting the function, quality of life, and longev- ity. 71 Apart from genetic endowment, an individual must also interact with environmental factors associated with longevity. One of these factors includes maintaining high level of physical activity. 72 Chronic endurance training will attenuate the decline in maximal oxygen uptake associated with age. 61,73 In addition, antiaging effects have also been ascribed to aerobic exercise training. 67 An association between muscle function and s-Klotho expression has been previously suggested from longitudinal cohort studies. 23 A direct relationship between circulating s-Klotho and IGF-I following aerobic exercise training has been recently investigated. 45 This study demonstrated that circulating s-Klotho levels are similar for young healthy well-trained elite runners and master athletes. It seems that the response depends on aerobic fitness level. 42 In addition, levels of s-Klotho were significantly higher in both groups when compared with untrained subjects as reported earlier. 46 Since aging is an independent risk factor for age-related diseases and mortality, there are growing efforts in geron- tology research to slow aging and extend healthy life span. The population aged from birth to 91 years screened pre- viously by ELISA revealed that the level of s-Klotho declines with aging. 19 On the other hand, at any age, elderly individuals with aerobic capacity have longer life expec- tancies compared to inactive people. 39,47 4 Journal of Circulating Biomarkers While in the aerobic-trained young runners and master athletes, the s-Klotho levels were markedly elevated and the IGF-I levels were decreased compared with sedentary young and old subjects. 48 The scientific evidence suggests that IGF-I signaling through IGF-I and insulin receptors is related to a shortened life span in adults. 50 In addition, a meta-analysis study indicated that increased circulating concentrations of IGF-I are associated with increased risks of colorectal, prostate, and premenopausal breast cancers. 51 Exercise, s-Klotho, and IGF-I in CAD CAD is a highly prevalent disease in the general adult population and is a major cause of death. Several clinical studies have suggested that Klotho gene exerts strong car- dioprotective effects. s-Klotho has been proposed as a key regulator of the development of cardiovascular disease. In the few published clinical studies, an association between low levels of s-Klotho and the occurrence and severity of cardiovascular disease have been reported as well as a reduction in cardiovascular risk when levels were high. 74 Earlier, a relationship between low levels of s-Klotho and the occurrence and severity of CAD as well as a reduction in cardiovascular risk when they are high are observed. 74 Diverse studies suggest that alterations in the levels of this molecule may be associated with pathophysiological abnormalities that result in increased cardiovascular risk. 75 This protein is related to the attenuation of vascular calci- fication as well as prevention of cardiac hypertrophy. For instance, Klotho gene has been shown to protect against vascular calcifications in rodent models of CAD. While in humans without CAD, higher s-Klotho levels have been related to a lower incidence of mortality and CAD, 68,75 while low s-Klotho levels have been associated with increased arterial stiffness in chronic kidney disease patients. 63 Additionally, several experimental studies indi- cate that s-Klotho facilitates the maintenance of vascular homeostasis. s-Klotho improves endothelial dysfunction through promotion of nitric oxide (NO) production and mediates anti-inflammatory and antiaging effects such as suppression of adhesion molecules expression, attenuation of nuclear factor-k B or inhibition of Wnt signaling, thus, limits Wnt-mediated cellular senescence. 76 Aerobic exercise training increases resistance vessel sensitivity and maximal responsiveness to adenosine. This has been confirmed in dogs and miniature swine in vivo. 77 Aerobic exercise and Klotho gene expression could reduce the risk of cardiovascular events in patients with prior CAD, it may decrease the risk of mortality, 68,78 incidence, and severity of cardiac events. 79,80 Furthermore, in patients with CAD, exercise training improves endothelium- dependent vasodilatation both in epicardial coronary ves- sels and in resistance vessels. 81 Patients with significant CAD present lower concentra- tions of s-Klotho as well as reduced expression of Klotho gene in the vascular wall. The exonic variant KL-VS was associated with the incidence of atherosclerotic vascular disease and CAD. 75 Saghiv et al. 82 assessed the effect of chronic aerobic exercise training on s-Klotho serum levels and IGF-I levels in CAD patients following long-lasting aerobic exercise training. The study demonstrated that in aerobically trained CAD patients, circulating s-Klotho levels were signifi- cantly higher, while IGF-I were significantly lower com- pared to untrained CAD patients and their healthy untrained counterpartners. In trained CAD patients, these findings suggest that in CAD patients, circulating s-Klotho levels are augmented in response to long-lasting aerobic exercise training. The reduced s-Klotho levels observed in the untrained CAD patients 82 was similar to other pre- mature vascular aging diseases, such as hypertension or diabetes mellitus. 75 Further support for a direct role of Klotho gene in vascular homeostasis comes from in vitro studies showing endogenous expression of Klotho gene in human vascular smooth muscle cells. 83 Conclusions Inflection of Klotho expression through aerobic exercise training represents an interesting relationship that may con- tribute to the explanation of the antiaging and anti-CAD effects of long-lasting aerobic activity. Both are factors that may promote upgrading capacities of the elderly, CAD patients and healthy young adult subjects. Accordingly, a long-lasting aerobically trained individual is associated with decreased risk factors and increased s-Klotho that clearly counteracts the action of IGF-I. Following anaero- bic exercise training, there is no association with circulat- ing s-Klotho; however, it is a potent stimulus to increase plasma IGF-I levels. Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding The author(s) received no financial support for the research, authorship, and/or publication of this article. References 1. Ling C and Ronn T. Epigenetic adaptation to regular exercise in humans. Drug Discov Today 2014; 19: 1015–1018. 2. Radom-Aizik S, Zaldivar F Jr, Leu SY, et al. A brief bout of exercise alters gene expression and distinct gene pathways in peripheral blood mononuclear cells of early- and late- pubertal females. J Appl Physiol (1985) 2009; 107: 168–175. 3. Denham J, Marques FZ, O’Brien BJ, et al. Exercise: putting action into our epigenome. J Sports Med 2014; 44: 189–209. 4. Bian A, Neyra JA, Zhan M, et al. Klotho, stem cells, and aging. Clin Interv Aging 2015; 10: 1233–1243. Saghiv et al. 5 5. Matsubara T, Miyaki A, Akazawa N, et al. Aerobic exercise training increases plasma Klotho levels and reduces arterial stiffness in postmenopausal women. Am J Physiol Heart Circ Physiol 2014; 306: H348–H355. 6. Edgett BA, Foster WS, Hankinson PB, et al. Dissociation of increases in PGC-1a and its regulators from exercise intensity and muscle activation following acute exercise. PLoS One 2013; 8(8): e71623. 7. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45–51. 8. Rubinek T and Modan-Moses D. Klotho and the growth hor- mone/insulin-like growth factor 1 axis: novel insights into complex interactions. Vitam Horm 2016; 101: 85–118. 9. Avin KG, Coen PM, Huang W, et al. Skeletal muscle as a regulator of the longevity protein, Klotho. Front Physiol 2014; 5: 189. DOI: 10.3389/fphys.2014.00189. 10. Wang Y and Sun Z. Current understanding of Klotho. Ageing Res Rev 2009; 8: 43–51. 11. Wang Y and Sun Z. Antiaging gene Klotho regulates endothelin-1 levels and endothelin receptor subtype B expression in kidneys of spontaneously hypertensive rats. J Hypertens 2014; 32: 1629–1636. 12. Kuro-o M. Klotho as a regulator of oxidative stress and senes- cence. Biol Chem 2008; 389: 233–241. 13. Xiao NM, Zhang YM, Zheng Q, et al. Klotho is a serum factor related to human aging. Chin Med J (Engl) 2004; 117: 742–747. 14. Huang CL. Regulation of ion channels by secreted Klotho: mechanisms and implications. Kidney Int 2010; 77: 855–860. 15. Liu BC, Yang LL, Lu XY, et al. Lovastatin-induced phosphatidylinositol-4-phosphate 5-kinase diffusion from microvilli stimulates ROMK channels. J Am Soc Nephrol 2015; 26: 1576–1587. 16. Medici D, Razzaque MS, Deluca S, et al. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D- induced apoptosis. J Cell Biol 2008; 182: 459–465. 17. Kuro-o M. Klotho and aging. Biochim Biophys Acta 2009; 1790: 1049–1058. 18. Sopjani M, Rinnerthaler M, Kruja J, et al. Intracellular sig- naling of the aging suppressor protein Klotho. Curr Mol Med 2015; 15: 27–37. 19. Crasto CL, Semba RD, Sun K, et al. Relationship of low- circulating “anti-aging” Klotho hormone with disability in activities of daily living among older community-dwelling adults. Rejuvenation Res 2012; 15: 295–301. 20. Semba RD, Cappola AR, Sun K, et al. Plasma Klotho and mortality risk in older community-dwelling adults. J Geron- tol A Biol Sci Med Sci 2011; 66: 794–800. 21. Semba RD, Cappola AR, Sun K, et al. Relationship of low plasma Klotho with poor grip strength in older community- dwelling adults: the InCHIANTI study. Eur. J. Appl. Physiol 2012; 112: 1215–1220. 22. Laviola L, Natalicchio A, and Giorgino F. The IGF-I signal- ing pathway. Curr Pharm Des 2007; 13: 663–669. 23. Barton ER, Park S, James JK, et al. Deletion of Muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. FASEB J 2012; 26: 3691–3702. 24. Higashi Y, Sukhanov S, Anwar A, et al. Aging, atherosclero- sis, and IGF-I. J Gerontol 2012; 67A: 626–639. 25. LeRoith D and Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195: 127–137. 26. Kooijman R. Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev 2006;17: 305–323. 27. Werner H and Bruchim I. The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 2009; 115: 58–71. 28. Florini JR, Ewton DZ, and Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 1996; 17: 481–517. 29. Piovezan RD, Abucham J, Dos Santos RV, et al. The impact of sleep on age-related sarcopenia: possible connections and clin- ical implications. Ageing Res Rev 2015; 23 (Pt B): 210–220. 30. Hameed M, Harridge SD, and Goldspink G. Sarcopenia and hypertrophy: a role for insulin-like growth factor-1 in aged muscle. Exerc Sport Sci Rev 2002; 30: 15–19. 31. Maeda S, Sugawara J, Yoshizawa M, et al. Involvement of endothelin-1 in habitual exercise-induced increase in arterial compliance. Acta Physiol Oxf 2009; 196: 223–229. 32. Lesniewski LA, Durrant JR, Connell ML, et al. Aerobic exer- cise reverses arterial inflammation with aging in mice. Am J Physiol Heart Circ Physiol 2011; 301: H102–H1032. 33. Jazwinski SM. Longevity, genes, and aging. Science 1996; 273: 54–59. 34. Pfeifle B, Hamann H, Fussganger R, et al. Insulin as a growth regulator of arterial smooth muscle cells: effect of insulin and IGF-I. Diabetes Metab 1987; 13: 326–330. 35. Bayes-Genis A, Conover CA, and Schwartz RS. The insulin- like growth factor axis: a review of atherosclerosis and rest- enosis. Circ Res 2000; 86: 125–130. 36. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, et al. American College of Sports Medicine Position Stand. Exer- cise and physical activity for older adults. Med Sci Sports Exerc 2009; 41: 1510–1530. 37. Paffenbarger RS Jr, Blair SN, and Lee IM. A history of physical activity, cardiovascular health and longevity: the scientific contributions of Jeremy N Morris, DSc, DPH, FRCP. Int J Epidemiol 2001; 30(5): 1184–1192. 38. Teramoto M and Bungum TJ. Mortality and longevity of elite athletes. J Sci Med Sport 2010; 13: 410–416. 39. Apor P and Radi A. Master sportsmen. Health status and life expectancies of physically active elderly. Orv Hetil (Hungar- ian) 2010; 151: 110–113 40. Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769–1775. 41. Binder EF, Schechtman KB, Ehsani AA, et al. Effects of exercise training on frailty in community-dwelling elderly adults: results of a randomized, controlled trial. J Am Geriatr Soc 2002; 50: 1921–1928. 6 Journal of Circulating Biomarkers 42. Reimers CD, Knapp G, and Reimers AK. Does physical activity increase life expectancy? A review of the literature. J Aging Res 2012; 2012. DOI: 10.1155/2012/243958. 43. Schefer V and Talan MI. Oxygen consumption in adult and aged C57BL/6J mice during acute treadmill exercise of dif- ferent intensity. Exp Gerontol 1996; 31: 387–392. 44. Phelps M, Pettan-Brewer C, Ladige W, et al. Decline in mus- cle strength and running endurance in Klotho deficient C57BL/6 mice. Biogerontology 2013; 14: 729–739. 45. Saghiv M, Goldhammer E, Sagiv M, et al. Effects of aerobic exercise training on s-Klotho in young and elderly. J J Phy- siology 2015; 1(1): 001. 46. Lee EY, Kim SS, Lee JS, et al. Soluble a-Klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes. Plos One 2014; 9(8): e102984. DOI: 10.1371/ journal.pone.0102984. 47. Paffenbarger RS Jr, Kampert JB, and Lee IM. Physical activ- ity and health of college men: longitudinal observations. Int J Sports Med 1997; 18(Suppl 3): S200–S203. 48. Manetta J, Brun JF, Fedou C, et al. Serum levels of insulin- like growth factor-I [IGF-I], and IGF-binding proteins-1 and - 3 in middle-aged and young athletes versus sedentary men: relationship with glucose disposal. Metabolism 2003; 52: 821–826. 49. Bonnefoy M, Patricot MC, Lacour JR, et al. Relation between physical activity, muscle function and IGF-I, testosterone and DHEAS concentrations in the elderly. Rev Med Interne (in French) 2002; 23: 819–827. 50. Berryman DE, Christiansen JS, Johannsson G, et al. Role of the GH/IGF-I axis in lifespan and health span: lessons from animal models. Growth Horm IGF Res 2008; 18: 455–471. 51. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250–252. 52. Chateau MT, Araiz C, Descamps S, et al. Klotho interferes with a novel FGF-signaling pathway and insulin/IGF-like signaling to improve longevity and stress resistance in Cae- norhabditis Elegans. Aging 2010; 2: 567–581. 53. Vale RG, de Oliveira RD, Pernambuco CS, et al. Effects of muscle strength and aerobic training on basal serum levels of IGF-I and cortisol in elderly women. Arch Gerontol Geriatr 2009; 49: 343–347. 54. Costill DL, Barnett A, Sharp R, et al. Leg muscle pH following sprint running. Med Sci Sports Exerc 1983; 15: 325–329. 55. Qiao D, Hou L, and Liu X. Influence of intermittent anaero- bic exercise on mouse physical endurance and antioxidant components. Br J Sports Med 2006; 40: 214–218. 56. Devaraj S, Syed B, Chien A, et al. Validation of an immu- noassay for soluble Klotho protein: decreased levels in dia- betes and increased levels in chronic kidney disease. Am J Clin Pathol 2012; 137: 479–485. 57. Eliakim A, Nemet D, Most G, et al. Effect of gender on the GH-IGF-I response to anaerobic exercise in young adults. J Strength Cond Res 2014; 28: 3411–3415. 58. Semba RD, Cappola AR, Sun K, et al. Plasma Klotho and cardiovascular disease in adults. J Am Geriatr Soc 2011; 59: 1596–1601. 59. Neidert MC, Sze L, Zwimpfer C, et al. Soluble a-Klotho: a novel serum biomarker for the activity of GH-producing pituitary adenomas. Eur J Endocrinol 2013; 68: 575–583. 60. Saghiv M, Ben Sira D, and Sagiv M. Comparison between aerobic and anaerobic training influence on s-Klotho blood levels following 60 min aerobic bout. J J Physiology 2015; 1(1): 004. 61. Hawkins S and Wiswell R. Rate and mechanism of maximal oxygen consumption decline with aging: implications for exercise training. Sports Med 2003; 33: 877–888. 62. Gault ML and Willems MET. Aging, functional capacity and eccentric exercise training. Aging Dis 2013; 4: 351–363. 63. Aizawa H, Iida A, Iwasaki H, et al. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45–51. 64. Sebastiani P, Solovieff N, Puca A, et al. Genetic signatures of exceptional longevity in humans. Science Epub ahead of print 1 July 2010. DOI: 10.1126/science.1190532. 65. Thomas L, Levett K, Boyd A, et al. Changes in regional left atrial function with aging: evaluation by Doppler tissue ima- ging. Eur J Echocardiogr 2003; 4: 92–100. 66. Ambrosio F, Avin KG, Coen PM, et al. Skeletal muscle as a regulator of the longevity protein, Klotho. Front Physiol 2014; 5: 189. DOI: 10.3389/fphys.2014.00189. eCollection 2014. 67. Bartke A.Long-lived Klotho mice: new insights into the roles of IGF-I and insulin in aging. Trends Endocrinol Metab 2006; 17: 33–35. 68. Donate-Correa J, Martı́nez-Sanz R, Mora-Fernandez C, et al. Reduced Klotho is associated with the presence and severity of coronary artery disease. Heart 2014; 100: 34–40. 69. Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science 2005; 309: 1829–1833. 70. Yamamoto M, Clark JD, Pastor JV, et al. Regulation of oxidative stress by the anti-aging hormone Klotho. J Biol Chem 2005; 280: 38029–38034. 71. Afilalo J, Karunananthan S, Eisenberg MJ, et al. Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009; 103: 1616–1621. 72. Baldwin KM and Haddad F. Research in the exercise sciences: where we are and where do we go from here—Part II. Exerc Sport Sci Rev 2010; 38: 42–50. 73. Buford TW, MacNeil RG, Clough LG, et al. Active muscle regeneration following eccentric contraction-induced injury is similar between healthy young and older adults. J Appl Physiol (1985) 2014; 116: 1481–1490. 74. Martı́n-Núñez E, Donate-Correa J, Muros-de-Fuentes M, et al. Implications of Klotho in vascular health and disease. World J Cardiol 2014; 6: 1262–1269. 75. Donate-Correa J, Martı́n-Núñez E, Martı́nez-Sanz R, et al. Influence of Klotho gene polymorphisms on vascular gene Saghiv et al. 7 expression and its relationship to cardiovascular disease. J Cell Mol Med 2016; 20: 128–313. 76. Zong P, Sun W, Setty S, et al. Alpha-adrenergic vasoconstric- tor tone limits right coronary blood flow in exercising dogs. Exp Biol Med (Maywood) 2004; 229: 312–322. 77. Cornish S, Herrmann N, Lanctot K, et al. Exercise interven- tion and inflammatory markers in coronary artery disease: a meta-analysis. Am Heart J 2012; 163: 666–676. 78. Kodama S, Kondo K, Ohashi Y, et al. Effect of aerobic exer- cise training on serum levels of high-density lipoprotein cho- lesterol: a meta-analysis. Arch Intern Med 2007; 167: 999–1008. 79. Bikdeli B, Ranasinghe I, Chen R, et al. Most important out- comes research papers on treatment of stable coronary artery disease. Circ Cardiovasc Qual Outcomes 2013; 6: e17–e25. 80. Erbs S, Gielen S, Hambrecht R, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000; 342: 454–460. 81. Saghiv M, Sherve C, Ben Sira D, et al. Aerobic training effect on blood s-Klotho levels in coronary artery disease patients. J Clin Exp Cardiol 2016; 7(8): 464. 82. Inoue T, Ito H, Kikumoto Y, et al. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One 2013; 8(2): e56695. DOI: 10.1371/journal.pone. 0056695. Epub 2013 Feb 19. 83. Buiten MS, de Bie MK, Bouma-de Krijger A, et al. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients. BMC Nephrology 2014; 11: 197. 8 Journal of Circulating Biomarkers << /ASCII85EncodePages false /AllowTransparency false /AutoPositionEPSFiles true /AutoRotatePages /None /Binding /Left /CalGrayProfile (Gray Gamma 2.2) /CalRGBProfile (sRGB IEC61966-2.1) /CalCMYKProfile (U.S. Web Coated \050SWOP\051 v2) /sRGBProfile (sRGB IEC61966-2.1) /CannotEmbedFontPolicy /Warning /CompatibilityLevel 1.4 /CompressObjects /Off /CompressPages true /ConvertImagesToIndexed true /PassThroughJPEGImages false /CreateJobTicket false /DefaultRenderingIntent /Default /DetectBlends true /DetectCurves 0.1000 /ColorConversionStrategy /LeaveColorUnchanged /DoThumbnails false /EmbedAllFonts true /EmbedOpenType false /ParseICCProfilesInComments true /EmbedJobOptions true /DSCReportingLevel 0 /EmitDSCWarnings false /EndPage -1 /ImageMemory 1048576 /LockDistillerParams true /MaxSubsetPct 100 /Optimize true /OPM 1 /ParseDSCComments true /ParseDSCCommentsForDocInfo true /PreserveCopyPage true /PreserveDICMYKValues true /PreserveEPSInfo true /PreserveFlatness false /PreserveHalftoneInfo false /PreserveOPIComments false /PreserveOverprintSettings true /StartPage 1 /SubsetFonts true /TransferFunctionInfo /Apply /UCRandBGInfo /Remove /UsePrologue false /ColorSettingsFile () /AlwaysEmbed [ true ] /NeverEmbed [ true ] /AntiAliasColorImages false /CropColorImages false /ColorImageMinResolution 266 /ColorImageMinResolutionPolicy /OK /DownsampleColorImages true /ColorImageDownsampleType /Average /ColorImageResolution 175 /ColorImageDepth -1 /ColorImageMinDownsampleDepth 1 /ColorImageDownsampleThreshold 1.50286 /EncodeColorImages true /ColorImageFilter /DCTEncode /AutoFilterColorImages true /ColorImageAutoFilterStrategy /JPEG /ColorACSImageDict << /QFactor 0.40 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /ColorImageDict << /QFactor 0.76 /HSamples [2 1 1 2] /VSamples [2 1 1 2] >> /JPEG2000ColorACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /JPEG2000ColorImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /AntiAliasGrayImages false /CropGrayImages false /GrayImageMinResolution 266 /GrayImageMinResolutionPolicy /OK /DownsampleGrayImages true /GrayImageDownsampleType /Average /GrayImageResolution 175 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50286 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict << /QFactor 0.40 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /GrayImageDict << /QFactor 0.76 /HSamples [2 1 1 2] /VSamples [2 1 1 2] >> /JPEG2000GrayACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /JPEG2000GrayImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /AntiAliasMonoImages false /CropMonoImages false /MonoImageMinResolution 900 /MonoImageMinResolutionPolicy /OK /DownsampleMonoImages true /MonoImageDownsampleType /Average /MonoImageResolution 175 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50286 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict << /K -1 >> /AllowPSXObjects false /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox false /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile (U.S. Web Coated \050SWOP\051 v2) /PDFXOutputConditionIdentifier (CGATS TR 001) /PDFXOutputCondition () /PDFXRegistryName (http://www.color.org) /PDFXTrapped /Unknown /CreateJDFFile false /Description << /ENU >> /Namespace [ (Adobe) (Common) (1.0) ] /OtherNamespaces [ << /AsReaderSpreads false /CropImagesToFrames true /ErrorControl /WarnAndContinue /FlattenerIgnoreSpreadOverrides false /IncludeGuidesGrids false /IncludeNonPrinting false /IncludeSlug false /Namespace [ (Adobe) (InDesign) (4.0) ] /OmitPlacedBitmaps false /OmitPlacedEPS false /OmitPlacedPDF false /SimulateOverprint /Legacy >> << /AllowImageBreaks true /AllowTableBreaks true /ExpandPage false /HonorBaseURL true /HonorRolloverEffect false /IgnoreHTMLPageBreaks false /IncludeHeaderFooter false /MarginOffset [ 0 0 0 0 ] /MetadataAuthor () /MetadataKeywords () /MetadataSubject () /MetadataTitle () /MetricPageSize [ 0 0 ] /MetricUnit /inch /MobileCompatible 0 /Namespace [ (Adobe) (GoLive) (8.0) ] /OpenZoomToHTMLFontSize false /PageOrientation /Portrait /RemoveBackground false /ShrinkContent true /TreatColorsAs /MainMonitorColors /UseEmbeddedProfiles false /UseHTMLTitleAsMetadata true >> << /AddBleedMarks false /AddColorBars false /AddCropMarks false /AddPageInfo false /AddRegMarks false /BleedOffset [ 9 9 9 9 ] /ConvertColors /ConvertToRGB /DestinationProfileName (sRGB IEC61966-2.1) /DestinationProfileSelector /UseName /Downsample16BitImages true /FlattenerPreset << /ClipComplexRegions true /ConvertStrokesToOutlines false /ConvertTextToOutlines false /GradientResolution 300 /LineArtTextResolution 1200 /PresetName ([High Resolution]) /PresetSelector /HighResolution /RasterVectorBalance 1 >> /FormElements true /GenerateStructure false /IncludeBookmarks false /IncludeHyperlinks false /IncludeInteractive false /IncludeLayers false /IncludeProfiles true /MarksOffset 9 /MarksWeight 0.125000 /MultimediaHandling /UseObjectSettings /Namespace [ (Adobe) (CreativeSuite) (2.0) ] /PDFXOutputIntentProfileSelector /DocumentCMYK /PageMarksFile /RomanDefault /PreserveEditing true /UntaggedCMYKHandling /UseDocumentProfile /UntaggedRGBHandling /UseDocumentProfile /UseDocumentBleed false >> ] /SyntheticBoldness 1.000000 >> setdistillerparams << /HWResolution [288 288] /PageSize [612.000 792.000] >> setpagedevice